Receptor programowanej śmierci 1 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptor programowanej śmierci 1" in Polish language version.

refsWebsite

Global rank Polish rank

12worldcat.org

5^th place

2^nd place

11doi.org

2^nd place

6^th place

9nih.gov

4^th place

7^th place

2sciencedirect.com

149^th place

235^th place

1sciencemag.org

857^th place

738^th place

1jimmunol.org

low place

1nature.com

234^th place

204^th place

doi.org

dx.doi.org

Znaczenie receptora programowanej śmierci 1 oraz jego ligandów w układzie immunologicznym oraz nowotworach, „Acta Haematologica Polonica”, 43 (2), 2012, s. 132–145, DOI: 10.1016/S0001-5814(12)32008-2, ISSN 0001-5814 (pol.).
FenF. Huang FenF. i inni, MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells, „Oncology Letters”, 15 (4), 2018, s. 4797–4804, DOI: 10.3892/ol.2018.7951, ISSN 1792-1074, PMID: 29552119, PMCID: PMC5840577 .
T.T. Shinohara T.T. i inni, Structure and chromosomal localization of the human PD-1 gene (PDCD1), „Genomics”, 23 (3), 1994, s. 704–706, DOI: 10.1006/geno.1994.1562, ISSN 0888-7543, PMID: 7851902 [dostęp 2018-04-19] .
EnfuE. Hui EnfuE. i inni, T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, „Science”, 355 (6332), 2017, s. 1428–1433, DOI: 10.1126/science.aaf1292, ISSN 0036-8075, PMID: 28280247 (ang.).
PierreP. Serra PierreP. i inni, Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma, „Lung Cancer (Amsterdam, Netherlands)”, 118, 2018, s. 62–68, DOI: 10.1016/j.lungcan.2018.02.005, ISSN 1872-8332, PMID: 29572005 [dostęp 2018-04-19] .
AudreyA. Monneur AudreyA., AnthonyA. Gonçalves AnthonyA., FrançoisF. Bertucci FrançoisF., [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer], „Bulletin Du Cancer”, 105 (3), 2018, s. 263–274, DOI: 10.1016/j.bulcan.2017.11.012, ISSN 1769-6917, PMID: 29455872 [dostęp 2018-04-19] .
Peter T.P.T. Sage Peter T.P.T. i inni, Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function, „The Journal of Immunology”, 200 (8), 2018, s. 2592–2602, DOI: 10.4049/jimmunol.1701231, ISSN 0022-1767, PMID: 29531164 (ang.).
ManoloM. Sambucci ManoloM. i inni, FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis, „Scientific Reports”, 8 (1), 2018, DOI: 10.1038/s41598-018-21861-5, ISSN 2045-2322 (ang.).
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease, „Tuberculosis”, 110, 2018, s. 7–14, DOI: 10.1016/j.tube.2018.03.001, ISSN 1472-9792 (ang.).
PoonamP. Mathur PoonamP. i inni, Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis, „Journal of Medical Virology”, 90 (5), 2018, s. 936–941, DOI: 10.1002/jmv.25002, ISSN 1096-9071, PMID: 29236302, PMCID: PMC5849501 [dostęp 2018-04-19] .
Yuan-MeiY.M. Che Yuan-MeiY.M. i inni, In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis, „Journal of Cellular Biochemistry”, 119 (4), 2018, s. 3044–3057, DOI: 10.1002/jcb.26432, ISSN 1097-4644, PMID: 29058791 [dostęp 2018-04-19] .

jimmunol.org

Peter T.P.T. Sage Peter T.P.T. i inni, Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function, „The Journal of Immunology”, 200 (8), 2018, s. 2592–2602, DOI: 10.4049/jimmunol.1701231, ISSN 0022-1767, PMID: 29531164 (ang.).

nature.com

ManoloM. Sambucci ManoloM. i inni, FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis, „Scientific Reports”, 8 (1), 2018, DOI: 10.1038/s41598-018-21861-5, ISSN 2045-2322 (ang.).

nih.gov

ncbi.nlm.nih.gov

FenF. Huang FenF. i inni, MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells, „Oncology Letters”, 15 (4), 2018, s. 4797–4804, DOI: 10.3892/ol.2018.7951, ISSN 1792-1074, PMID: 29552119, PMCID: PMC5840577 .
T.T. Shinohara T.T. i inni, Structure and chromosomal localization of the human PD-1 gene (PDCD1), „Genomics”, 23 (3), 1994, s. 704–706, DOI: 10.1006/geno.1994.1562, ISSN 0888-7543, PMID: 7851902 [dostęp 2018-04-19] .
Y.Y. Ishida Y.Y. i inni, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, „The EMBO journal”, 11 (11), 1992, s. 3887–3895, ISSN 0261-4189, PMID: 1396582, PMCID: PMC556898 [dostęp 2018-04-19] .
EnfuE. Hui EnfuE. i inni, T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, „Science”, 355 (6332), 2017, s. 1428–1433, DOI: 10.1126/science.aaf1292, ISSN 0036-8075, PMID: 28280247 (ang.).
PierreP. Serra PierreP. i inni, Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma, „Lung Cancer (Amsterdam, Netherlands)”, 118, 2018, s. 62–68, DOI: 10.1016/j.lungcan.2018.02.005, ISSN 1872-8332, PMID: 29572005 [dostęp 2018-04-19] .
AudreyA. Monneur AudreyA., AnthonyA. Gonçalves AnthonyA., FrançoisF. Bertucci FrançoisF., [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer], „Bulletin Du Cancer”, 105 (3), 2018, s. 263–274, DOI: 10.1016/j.bulcan.2017.11.012, ISSN 1769-6917, PMID: 29455872 [dostęp 2018-04-19] .
Peter T.P.T. Sage Peter T.P.T. i inni, Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function, „The Journal of Immunology”, 200 (8), 2018, s. 2592–2602, DOI: 10.4049/jimmunol.1701231, ISSN 0022-1767, PMID: 29531164 (ang.).
PoonamP. Mathur PoonamP. i inni, Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis, „Journal of Medical Virology”, 90 (5), 2018, s. 936–941, DOI: 10.1002/jmv.25002, ISSN 1096-9071, PMID: 29236302, PMCID: PMC5849501 [dostęp 2018-04-19] .
Yuan-MeiY.M. Che Yuan-MeiY.M. i inni, In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis, „Journal of Cellular Biochemistry”, 119 (4), 2018, s. 3044–3057, DOI: 10.1002/jcb.26432, ISSN 1097-4644, PMID: 29058791 [dostęp 2018-04-19] .

sciencedirect.com

Znaczenie receptora programowanej śmierci 1 oraz jego ligandów w układzie immunologicznym oraz nowotworach, „Acta Haematologica Polonica”, 43 (2), 2012, s. 132–145, DOI: 10.1016/S0001-5814(12)32008-2, ISSN 0001-5814 (pol.).
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease, „Tuberculosis”, 110, 2018, s. 7–14, DOI: 10.1016/j.tube.2018.03.001, ISSN 1472-9792 (ang.).

sciencemag.org

science.sciencemag.org

EnfuE. Hui EnfuE. i inni, T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, „Science”, 355 (6332), 2017, s. 1428–1433, DOI: 10.1126/science.aaf1292, ISSN 0036-8075, PMID: 28280247 (ang.).

worldcat.org

Znaczenie receptora programowanej śmierci 1 oraz jego ligandów w układzie immunologicznym oraz nowotworach, „Acta Haematologica Polonica”, 43 (2), 2012, s. 132–145, DOI: 10.1016/S0001-5814(12)32008-2, ISSN 0001-5814 (pol.).
FenF. Huang FenF. i inni, MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells, „Oncology Letters”, 15 (4), 2018, s. 4797–4804, DOI: 10.3892/ol.2018.7951, ISSN 1792-1074, PMID: 29552119, PMCID: PMC5840577 .
T.T. Shinohara T.T. i inni, Structure and chromosomal localization of the human PD-1 gene (PDCD1), „Genomics”, 23 (3), 1994, s. 704–706, DOI: 10.1006/geno.1994.1562, ISSN 0888-7543, PMID: 7851902 [dostęp 2018-04-19] .
Y.Y. Ishida Y.Y. i inni, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, „The EMBO journal”, 11 (11), 1992, s. 3887–3895, ISSN 0261-4189, PMID: 1396582, PMCID: PMC556898 [dostęp 2018-04-19] .
EnfuE. Hui EnfuE. i inni, T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition, „Science”, 355 (6332), 2017, s. 1428–1433, DOI: 10.1126/science.aaf1292, ISSN 0036-8075, PMID: 28280247 (ang.).
PierreP. Serra PierreP. i inni, Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma, „Lung Cancer (Amsterdam, Netherlands)”, 118, 2018, s. 62–68, DOI: 10.1016/j.lungcan.2018.02.005, ISSN 1872-8332, PMID: 29572005 [dostęp 2018-04-19] .
AudreyA. Monneur AudreyA., AnthonyA. Gonçalves AnthonyA., FrançoisF. Bertucci FrançoisF., [PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer], „Bulletin Du Cancer”, 105 (3), 2018, s. 263–274, DOI: 10.1016/j.bulcan.2017.11.012, ISSN 1769-6917, PMID: 29455872 [dostęp 2018-04-19] .
Peter T.P.T. Sage Peter T.P.T. i inni, Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function, „The Journal of Immunology”, 200 (8), 2018, s. 2592–2602, DOI: 10.4049/jimmunol.1701231, ISSN 0022-1767, PMID: 29531164 (ang.).
ManoloM. Sambucci ManoloM. i inni, FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis, „Scientific Reports”, 8 (1), 2018, DOI: 10.1038/s41598-018-21861-5, ISSN 2045-2322 (ang.).
Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease, „Tuberculosis”, 110, 2018, s. 7–14, DOI: 10.1016/j.tube.2018.03.001, ISSN 1472-9792 (ang.).
PoonamP. Mathur PoonamP. i inni, Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis, „Journal of Medical Virology”, 90 (5), 2018, s. 936–941, DOI: 10.1002/jmv.25002, ISSN 1096-9071, PMID: 29236302, PMCID: PMC5849501 [dostęp 2018-04-19] .
Yuan-MeiY.M. Che Yuan-MeiY.M. i inni, In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis, „Journal of Cellular Biochemistry”, 119 (4), 2018, s. 3044–3057, DOI: 10.1002/jcb.26432, ISSN 1097-4644, PMID: 29058791 [dostęp 2018-04-19] .